A Safety, Tolerability, and Biomarker Trial of VS-041 in Participants With Heart Failure With Preserved Ejection Fraction (HFpEF)
NCT07219511
This study is recruiting at 19 US sites in 11 states, according to its ClinicalTrials.gov record last updated .
Summary
A Safety, Tolerability, and Biomarker Trial of VS-041 in Participants with Heart Failure with Preserved Ejection Fraction (HFpEF)
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Heart
- Heart Failure With Preserved Ejection Fraction (HFPEF)
Eligibility basics and study details
- Study type
- Interventional
- Phase
- Phase 1
- Ages
- 50 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Sponsor
- Vasa Therapeutics
- Last updated on ClinicalTrials.gov
- April 9, 2026
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
Arkansas · 1
- Cardiology and Medicine Clinic · Little Rock, AR
California · 3
- National Institute of Clinical Research · Huntington Beach, CA
- FOMAT · Santa Maria, CA
- Invivocure LLC · Van Nuys, CA
Florida · 4
- New Generation of Medical Research · Hialeah, FL
- Jacksonville Center for Clinical Research · Jacksonville, FL
- Amavita Health · North Miami Beach, FL
- Broward Research Center · Pembroke Pines, FL
Illinois · 2
- Eagle Clinical Research · Chicago, IL
- Chicago Medical Research · Hazel Crest, IL
Louisiana · 1
- Louisiana Heart Center · Slidell, LA
Missouri · 1
- Washington University · St Louis, MO
New Jersey · 1
- Ash Research Clinic · Brick, NJ
New York · 1
- Erie County Medical Center · Buffalo, NY
North Carolina · 2
- Duke University Medical Center · Durham, NC
- Wake Forest · Winston-Salem, NC
Oklahoma · 1
- Oklahoma Heart Hospital · Oklahoma City, OK
Texas · 2
- University of Texas Southwestern Medical Center · Dallas, TX
- LinQ Research, LLC · Tomball, TX
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.